The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence. Sang L, Cheng B, Yu Y, Xi Y, et al. J Infect 2022 Jun 9. pii: S0163-4453(22)00354.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sang L, Cheng B, Yu Y, Xi Y, et al. The efficacy and safety of IBI314 on Delta and Omicron variant of SARS-CoV-2: first-in-human evidence. J Infect 2022 Jun 9. pii: S0163-4453(22)00354.
PMID: 35691517